...
首页> 外文期刊>Journal of Medicinal Chemistry >Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
【24h】

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1

机译:咪唑异吲哚衍生物与IDO1的晶体结构揭示了吲哚胺2,3-二加氧酶1(IDO1)抑制剂设计中的重要氢键网络

获取原文
获取原文并翻译 | 示例
           

摘要

Indoleamine 2,3-dioxygenase 1 (IDO1), promoting immune escape of tumors, is a therapeutic target for the cancer immunotherapy. A number of IDO1 inhibitors have been identified, but only limited structural biology studies of IDO1 inhibitors are available to provide insights on the binding mechanism of IDO1. In this study, we present the structure of IDO1 in complex with 24, a NLG919 analogue with potent activity. The complex structure revealed the imidazole nitrogen atom of 24 to coordinate with the heme iron, and the imidazoleisoindole core situated in pocket A with the 1-cyclohexylethanol moiety extended to pocket B to interact with the surrounding residues. Most interestingly, 24 formed an extensive hydrogen bond network with IDO1, which is a distinct feature of IDO1/24 complex structure and is not observed in the other IDO1 complex structures. Further structure-activity relationship, UV spectra, and structural biology studies of several analogues of 24 demonstrated that extensive hydrophobic interactions and the unique hydrogen bonding network contribute to the great potency of imidazoleisoindole derivatives. These results are expected to facilitate the structure-based drug design of new IDO inhibitors.
机译:促进肿瘤免疫逃逸的吲哚胺2,3-二加氧酶1(IDO1)是癌症免疫疗法的治疗靶标。已经鉴定了许多IDO1抑制剂,但只有有限的IDO1抑制剂结构生物学研究可提供有关IDO1结合机理的见解。在这项研究中,我们提出了IDO1与24种具有有效活性的NLG919类似物复合的结构。复杂的结构显示咪唑氮原子为24,与血红素铁配位,咪唑异吲哚核心位于口袋A中,1-环己基乙醇部分延伸至口袋B与周围的残基相互作用。最有趣的是,24与IDO1形成了广泛的氢键网络,这是IDO1 / 24复杂结构的独特特征,而在其他IDO1复杂结构中则没有观察到。进一步的结构-活性关系,UV光谱和24种类似物的结构生物学研究表明,广泛的疏水性相互作用和独特的氢键网络有助于形成咪唑异吲哚衍生物。预期这些结果将有助于新型IDO抑制剂的基于结构的药物设计。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号